Skip to content
Brand AI

Phathom Pharmaceuticals, Inc.

Request correction

Corporate brand

UnclaimedRead 2× by AI crawlers

A biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal diseases.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Phathom Pharmaceuticals is a biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid-related gastrointestinal (GI) disorders. The company has licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB) for the treatment of certain GI disorders.

History

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases. It has licensed exclusive rights in the United States, Europe, and Canada to a potassium-competitive acid blocker (PCAB), which the company has been developing for the treatment of certain GI disorders.

Products and positioning

  • VOQUEZNA®

    A product offered by Phathom, with U.S. Prescribing Information available.

  • VOQUEZNA® Triple Pak® & Dual Pak®

    Products offered by Phathom, with U.S. Prescribing Information available.

Sources4 sources

  1. 1Phathom Pharmaceuticals – Leading the way to innovative treatments for gastrointestinal diseasesphathompharma.com
  2. 2About Us - Phathom Pharmaceuticalsphathompharma.com
  3. 3Our Products – Phathom Pharmaceuticalsphathompharma.com
  4. 4Phathom Pharmaceuticals, Inc. (United States)wikidata.org

Cite this profile: Cite the canonical profile. /brand-wiki/phathom-pharmaceuticals-inc-united-states · Editorial policy · How profiles are compiled